Old Web
English
Sign In
Acemap
>
Paper
>
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19.
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19.
2021
Maria Passante
Maddalena Napolitano
Stefano Dastoli
Luigi Bennardo
Gabriella Fabbrocini
Steven Paul Nisticò
Cataldo Patruno
Keywords:
Internal medicine
in patient
MEDLINE
Omalizumab
severe acute respiratory syndrome coronavirus 2
Medicine
Coronavirus disease 2019
viral infection
2019 20 coronavirus outbreak
Correction
Source
Cite
Save
Machine Reading By IdeaReader
8
References
1
Citations
NaN
KQI
[]